Turkey · Delayed Price · Currency is TRY IST:MEDTR Statistics
Total Valuation
IST:MEDTR has a market cap or net worth of TRY 3.22 billion. The enterprise value is 2.89 billion.
| Market Cap | 3.22B |
| Enterprise Value | 2.89B |
Important Dates
The next estimated earnings date is Thursday, May 7, 2026.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | Dec 31, 2025 |
Share Statistics
IST:MEDTR has 119.00 million shares outstanding.
| Current Share Class | 95.38M |
| Shares Outstanding | 119.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 79.41% |
| Owned by Institutions (%) | 5.43% |
| Float | 24.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.12 |
| PB Ratio | 1.10 |
| P/TBV Ratio | 1.14 |
| P/FCF Ratio | 12.83 |
| P/OCF Ratio | 7.39 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.08, with an EV/FCF ratio of 11.54.
| EV / Earnings | -312.12 |
| EV / Sales | 1.01 |
| EV / EBITDA | 11.08 |
| EV / EBIT | 34.18 |
| EV / FCF | 11.54 |
Financial Position
The company has a current ratio of 3.36, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.36 |
| Quick Ratio | 2.19 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.14 |
| Debt / FCF | 0.16 |
| Interest Coverage | 2.24 |
Financial Efficiency
Return on equity (ROE) is -0.40% and return on invested capital (ROIC) is 3.82%.
| Return on Equity (ROE) | -0.40% |
| Return on Assets (ROA) | 1.83% |
| Return on Invested Capital (ROIC) | 3.82% |
| Return on Capital Employed (ROCE) | 3.48% |
| Weighted Average Cost of Capital (WACC) | 7.32% |
| Revenue Per Employee | 3.61M |
| Profits Per Employee | -11,648 |
| Employee Count | 808 |
| Asset Turnover | 0.79 |
| Inventory Turnover | 3.29 |
Taxes
| Income Tax | -4.36M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.02% in the last 52 weeks. The beta is 0.36, so IST:MEDTR's price volatility has been lower than the market average.
| Beta (5Y) | 0.36 |
| 52-Week Price Change | -31.02% |
| 50-Day Moving Average | 29.42 |
| 200-Day Moving Average | 30.19 |
| Relative Strength Index (RSI) | 36.46 |
| Average Volume (20 Days) | 636,132 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IST:MEDTR had revenue of TRY 2.87 billion and -9.27 million in losses. Loss per share was -0.08.
| Revenue | 2.87B |
| Gross Profit | 824.69M |
| Operating Income | 106.24M |
| Pretax Income | -16.10M |
| Net Income | -9.27M |
| EBITDA | 273.30M |
| EBIT | 106.24M |
| Loss Per Share | -0.08 |
Balance Sheet
The company has 386.41 million in cash and 38.92 million in debt, with a net cash position of 347.49 million or 2.92 per share.
| Cash & Cash Equivalents | 386.41M |
| Total Debt | 38.92M |
| Net Cash | 347.49M |
| Net Cash Per Share | 2.92 |
| Equity (Book Value) | 2.93B |
| Book Value Per Share | 24.42 |
| Working Capital | 1.28B |
Cash Flow
In the last 12 months, operating cash flow was 435.35 million and capital expenditures -184.56 million, giving a free cash flow of 250.79 million.
| Operating Cash Flow | 435.35M |
| Capital Expenditures | -184.56M |
| Depreciation & Amortization | 176.42M |
| Net Borrowing | -29.76M |
| Free Cash Flow | 250.79M |
| FCF Per Share | 2.11 |
Margins
Gross margin is 28.70%, with operating and profit margins of 3.70% and -0.32%.
| Gross Margin | 28.70% |
| Operating Margin | 3.70% |
| Pretax Margin | -0.56% |
| Profit Margin | -0.32% |
| EBITDA Margin | 9.51% |
| EBIT Margin | 3.70% |
| FCF Margin | 8.73% |
Dividends & Yields
This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 0.93%.
| Dividend Per Share | 0.25 |
| Dividend Yield | 0.93% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 0.92% |
| Earnings Yield | -0.29% |
| FCF Yield | 7.79% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 22, 2022. It was a forward split with a ratio of 3.5.
| Last Split Date | Feb 22, 2022 |
| Split Type | Forward |
| Split Ratio | 3.5 |
Scores
IST:MEDTR has an Altman Z-Score of 5.36 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.36 |
| Piotroski F-Score | 4 |